Boyoung Y. Joung

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 494 publications

Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.

Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.

Journal: The New England journal of medicine

Published: August 28, 2026

Standard-dose direct oral anticoagulants for Asian patients with atrial fibrillation: the definitive case from COMBINE AF.

Standard-dose direct oral anticoagulants for Asian patients with atrial fibrillation: the definitive case from COMBINE AF.

Journal: European heart journal

Published: June 04, 2026

Lean body mass is the independent and predominant anthropometric variable associated with atrioventricular block.

Lean body mass is the independent and predominant anthropometric variable associated with atrioventricular block.

Journal: Heart rhythm O2

Published: May 25, 2026

Magnetically Guided Apoptotic Mesenchymal Stem Cell-Derived Nanovesicles for the Modulation of Pathological Remodeling in Cardiac Injury.

Magnetically Guided Apoptotic Mesenchymal Stem Cell-Derived Nanovesicles for the Modulation of Pathological Remodeling in Cardiac Injury.

Journal: Acta biomaterialia

Published: April 08, 2026

Efficacy and safety of direct oral anticoagulants for intermediate stroke risk in patients with atrial fibrillation (SINGLE-AF): Study design and protocol.

Efficacy and safety of direct oral anticoagulants for intermediate stroke risk in patients with atrial fibrillation (SINGLE-AF): Study design and protocol.

Journal: Heart rhythm O2

Published: March 30, 2026

Cognitive Function and Anticoagulation Discontinuation in Patients Without Long-Term Recurrence After Catheter Ablation for Atrial Fibrillation: A Substudy of the ALONE-AF Trial.

Cognitive Function and Anticoagulation Discontinuation in Patients Without Long-Term Recurrence After Catheter Ablation for Atrial Fibrillation: A Substudy of the ALONE-AF Trial.

Journal: Heart rhythm

Published: March 25, 2026

Moderate-to-Vigorous Intensity Physical Activity and Risk of Incident Atrial Fibrillation in Atrial Cardiomyopathy.

Moderate-to-Vigorous Intensity Physical Activity and Risk of Incident Atrial Fibrillation in Atrial Cardiomyopathy.

Journal: JACC. Advances

Published: March 12, 2026

Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in the AZALEA-TIMI 71 study.

Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in the AZALEA-TIMI 71 study.

Journal: Blood

Published: February 24, 2026

Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71.

Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71.

Journal: Blood

Published: February 24, 2026

Hemoglobin Decline After Oral Anticoagulation Initiation and Subsequent Cancer Detection in Patients With Atrial Fibrillation.

Hemoglobin Decline After Oral Anticoagulation Initiation and Subsequent Cancer Detection in Patients With Atrial Fibrillation.

Journal: JACC. CardioOncology

Published: February 20, 2026

Association between non-ablated left atrial surface area and rhythm outcome in patients treated with cryoballoon and radiofrequency ablation.

Association between non-ablated left atrial surface area and rhythm outcome in patients treated with cryoballoon and radiofrequency ablation.

Journal: Heart rhythm O2

Published: February 16, 2026

Association of Angiotensin Receptor Neprilysin Inhibitors Duration with Latent Remodeling Following Implantable Cardioverter Defibrillator Implantation.

Association of Angiotensin Receptor Neprilysin Inhibitors Duration with Latent Remodeling Following Implantable Cardioverter Defibrillator Implantation.

Journal: Heart rhythm

Published: February 11, 2026

Showing 1-12 of 494

Last Updated: 09/26/2026